Midas Pharma GmbH
Midas Pharma GmbH, a prominent player in the pharmaceutical industry, is headquartered in Germany and operates extensively across Europe and beyond. Founded in 1994, the company has established itself as a trusted partner in the development and distribution of innovative healthcare solutions. Midas Pharma focuses on contract development and manufacturing, offering a diverse range of services that include drug formulation, regulatory support, and supply chain management. Their commitment to quality and customer-centric approach sets them apart in a competitive market. With a strong emphasis on research and development, Midas Pharma has achieved significant milestones, positioning itself as a leader in the pharmaceutical sector. The company’s dedication to excellence is reflected in its robust portfolio of products and services, catering to the evolving needs of the healthcare landscape.
DitchCarbon Score
How does Midas Pharma GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Midas Pharma GmbH's score of 15 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Midas Pharma GmbH's reported carbon emissions
Midas Pharma GmbH, headquartered in Germany, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the company may still be engaged in industry-standard practices aimed at reducing carbon footprints and enhancing sustainability. As the global focus on climate action intensifies, Midas Pharma GmbH's future commitments and strategies will be crucial in aligning with broader environmental goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Midas Pharma GmbH is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
